
Merry Chen, M.D.
Department of Neuro-Oncology, Division of Cancer Medicine
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
2005 | State University of New York Downstate Medical Center, New York, NY, USA, MD, Medical Degree |
Postgraduate Training
2006-2009 | Clinical Residency, Adult Neurology, Tufts-New England Medical Center, Boston, MA |
2005-2006 | Clinical Residency, Internal Medicine PGY1, Lenox Hill Hospital, New York, NY |
Board Certifications
2009 | American Board of Psychiatry and Neurology |
Experience & Service
Academic Appointments
Fellow and Instructor, New York Presbyterian Hospital Weill Cornell Clincial Neurophysiology EEG/Epilepsy, New York, NY, 2009 - 2011
Selected Publications
Peer-Reviewed Articles
- Ezzeldin M, Yassin A, Fang X, Chen M. Episodic receptive aphasia associated with HSV-2 encephalitis. Neurologica Cases 2(2):8-10, 2015.
- Pemmaraju N, Sasaki K, Johnson D, Daver N, Afshar-Kharghan V, Chen M, Ahmed S, Colen RR, Kwon M, Huh Y, Borthakur G. Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the Literature. Front Oncol 5:29, 2015. e-Pub 2015. PMID: 25717439.
- Liao B, Kamiya-Matsuoka C, Gong Y, Chen M, Wolf BA, Fowler NH. Primary natural killer/T-cell lymphoma presenting as leptomeningeal disease. J Neurol Sci 343(1-2):46-50, 2014. e-Pub 2014. PMID: 24880537.
- Chen M, Lee G, Kwong LN, Lamont S, Chaves C. Cerebral white matter lesions in patients with Crohn's disease. J Neuroimaging 22(1):38-41, 2012. e-Pub 2010. PMID: 21091817.
Patient Reviews
CV information above last modified October 04, 2022
Request an Appointment
Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
Related Links
Clinical Trials
Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.